Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Galectin Therapeutics Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 60 | 1 | 60 | +1 |
| Shares | 7.28M | 3.92K | 9.06M | +1.79M (+24.6%) |
| Value | $10.5M | $5.64K | $17.4M | +$6.92M (+66.0%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Galectin Therapeutics Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Traynor Capital Management, Inc. | 34,707 | $66.6K | 0.01% |
| Wealth Enhancement Advisory Services, LLC | 18,639 | $35.8K | 0.00% |
| Retirement Guys Formula LLC | 11,500 | $22.1K | 0.02% |
| Qube Research & Technologies Ltd | 3,622 | $6.95K | 0.00% |
| Farther Finance Advisors, LLC | 350 | $672 | 0.00% |
Sold out (4)
Institutions that held Galectin Therapeutics Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Ameritas Advisory Services, LLC | 44,232 | $64.6K |
| Neuberger Berman Group LLC | 11,614 | $16.7K |
| Citadel Advisors LLC | 428 | $616 |
| Royal Bank of Canada | 324 | $0 |
Not filed for Q3 2023 yet (1)
Institutions that held Galectin Therapeutics Inc at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Coastal Capital Group, Inc. | 3,920 | $5.64K |